{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:39:53Z","timestamp":1774381193098,"version":"3.50.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Urolithiasis and symptomatic ureterolithiasis represent diseases known to be on the increase in most westernized countries. The present article aims to give an overview on some drug principles assumed to target signalling systems involved in modulating ureter smooth muscle contractility and to present background to their potential use or prospects in ureter stone disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The article reviews drugs that have been evaluated over the last decades in vitro, in vivo and\/or in clinical settings with regard to their properties to achieve spontaneous passage of (distal) ureteral stones and relieve colic pain. Among these drugs are alpha- and beta-adrenoceptor antagonists, calcium channel blocking agents, Rho kinase inhibitors, nitric oxide (NO) donor drugs, selective inhibitors of cyclic nucleotide phosphodiesterase enzymes (PDEs), as well as potassium channel openers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Based on the recent scientific information on agents targeting different pathways, antagonists of alpha 1-adrenoceptors, inhibitors of the PDE isoenzymes PDE4 and PDE5 (affecting cyclic AMP- or NO\/cyclic GMP-mediated signals that facilitate relaxation of ureter smooth muscle), as well as the combination of certain drugs (for example, PDE5\/PDE4 inhibitor plus alpha 1-AR antagonist) seem to be intriguing pharmacological approaches to medical expulsion therapy (MET) in the overall population of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>While NO donors, calcium channel antagonists and potassium channel openers may be limited for further development for medical expulsion therapy (MET) due to their systemic effects and a lack of effect on stone clearance, Rho kinase inhibitors should be explored further as a future pharmacological principle in ureteral stone disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-024-05368-5","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T19:24:58Z","timestamp":1732821898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drugs to affect the smooth musculature of the human ureter - an update with integrated information from basic science to the use in medical expulsion therapy (MET)"],"prefix":"10.1007","volume":"42","author":[{"given":"Petter","family":"Hedlund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrina E.","family":"Rahardjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7169-0385","authenticated-orcid":false,"given":"Stefan","family":"\u00dcckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"5368_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-981-13-5895-1_3","volume":"1124","author":"RJ Lang","year":"2019","unstructured":"Lang RJ, Hashitani H (2019) Pacemaker mechanisms driving pyelo-ureteric peristalsis: modulatory role of interstitial cells. Adv Exp Med Biol 1124:77\u2013101","journal-title":"Adv Exp Med Biol"},{"key":"5368_CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bjp.0703004","volume":"129","author":"P Santicioli","year":"2000","unstructured":"Santicioli P, Maggi CA (2000) Effect of 18 beta-glycyrrhetinic acid on electromechanical coupling in the guinea-pig renal pelvis and ureter. Br J Pharmacol 129:163\u2013169","journal-title":"Br J Pharmacol"},{"key":"5368_CR3","doi-asserted-by":"crossref","first-page":"19872","DOI":"10.1073\/pnas.0609326103","volume":"103","author":"ZX Mahoney","year":"2006","unstructured":"Mahoney ZX, Sammut B, Xavier RJ, Cunningham J, Go G, Brim KL, Stappenbeck TS, Miner JH, Swat W (2006) Discs-large homolog 1 regulates smooth muscle orientation in the mouse ureter. Proc Natl Acad Sci (PNAS) USA 103:19872\u201319877","journal-title":"Proc Natl Acad Sci (PNAS) USA"},{"key":"5368_CR4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00041.2019","volume":"100","author":"MG Dalghi","year":"2020","unstructured":"Dalghi MG, Montalbetti N, Carattino MD, Apodaca G (2020) The urothelium: life in a liquid environment. Physiol Rev 100:1621\u20131705","journal-title":"Physiol Rev"},{"key":"5368_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.euf.2022.09.014","volume":"9","author":"A Reicherz","year":"2023","unstructured":"Reicherz A, Eltit F, Almutairi K, Mojtahedzadeh B, Herout R, Chew B, Cox M, Lange D (2023) Ureteral obstruction promotes ureteral inflammation and fibrosis. Eur Urol Focus 9:371\u2013380","journal-title":"Eur Urol Focus"},{"key":"5368_CR6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-981-13-5895-1_4","volume":"1124","author":"T Burdyga","year":"2019","unstructured":"Burdyga T, Lang RJ (2019) Excitation-contraction coupling in ureteric smooth muscle: mechanisms driving ureteric peristalsis. Adv Exp Med Biol 1124:103\u2013119","journal-title":"Adv Exp Med Biol"},{"key":"5368_CR7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MNH.0000000000000478","volume":"28","author":"MR d\u2019Costa","year":"2019","unstructured":"d\u2019Costa MR, Pais VM, Rule AD (2019) Leave no stone unturned: defining recurrence in kidney stone formers. Curr Opin Nephrol Hypertens 28:148\u2013153","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5368_CR8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41581-020-0320-7","volume":"16","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon C, Krambeck AE, Rule AD (2020) Determining the true burden of kidney stone disease. Nat Rev Nephrol 16:736\u2013746","journal-title":"Nat Rev Nephrol"},{"key":"5368_CR9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/JU.0000000000001478","volume":"205","author":"P Jiang","year":"2021","unstructured":"Jiang P, Xie L, Arada R, Patel RM, Landman J, Clayman RV (2021) Qualitative review of clinical guidelines for medical and surgical management of urolithiasis: consensus and controversy 2020. J Urol 205:999\u20131008","journal-title":"J Urol"},{"key":"5368_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.euf.2022.06.014","volume":"9","author":"RM Geraghty","year":"2023","unstructured":"Geraghty RM, Davis NF, Tzelves L, Lombardo R, Yuan C, Thomas K, Petrik A, Neisius A, T\u00fcrk C, Gambaro G, Skolarikos A, Somani BK (2023) Best practice in interventional management of urolithiasis: an update from the European Association of Urology Guidelines Panel for Urolithiasis 2022. Eur Urol Focus 9:199\u2013208","journal-title":"Eur Urol Focus"},{"key":"5368_CR11","first-page":"227","volume":"3","author":"A Skolarikos","year":"2017","unstructured":"Skolarikos A, Ghani KR, Seitz C, van Asseldonk B, Bultitude MF (2017) Medical expulsive therapy in urolithiasis: a review of the quality of the current evidence. Eur Urol Focus 3:227\u2013245","journal-title":"Eur Urol Focus"},{"key":"5368_CR12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.eururo.2019.07.053","volume":"76","author":"V de Coninck","year":"2019","unstructured":"de Coninck V, Antonelli J, Chew B, Patterson JM, Skolarikos A, Bultitude M (2019) Medical expulsive therapy for urinary stones: future trends and knowledge gaps. Eur Urol 76:658\u2013666","journal-title":"Eur Urol"},{"key":"5368_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ucl.2021.12.007","volume":"49","author":"K Spradling","year":"2022","unstructured":"Spradling K, Ganesan C, Conti S (2022) Medical treatment and prevention of urinary stone disease. Urol Clin North Am 49:335\u2013344","journal-title":"Urol Clin North Am"},{"key":"5368_CR14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/nau.20097","volume":"24","author":"S Sigala","year":"2005","unstructured":"Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, Peroni A, Mirabella G, Cunico SC, Spano P, Muzzonigro G (2005) Evidence for the presence of alpha(1) adrenoceptor subtypes in the human ureter. Neurourol Urodyn 24:142\u2013148","journal-title":"Neurourol Urodyn"},{"key":"5368_CR15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00345-009-0396-y","volume":"27","author":"S Kobayashi","year":"2009","unstructured":"Kobayashi S, Tomiyama Y, Hoyano Y, Yamazaki Y, Kusama H, Itoh Y, Kubota Y, Kohri K (2009) Gene expressions and mechanical functions of alpha(1)-adrenoceptor subtypes in mouse ureter. World J Urol (WJU) 27:775\u2013780","journal-title":"World J Urol (WJU)"},{"key":"5368_CR16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.urology.2009.01.009","volume":"74","author":"S Kobayashi","year":"2009","unstructured":"Kobayashi S, Tomiyama Y, Hoyano Y, Yamazaki Y, Kusama H, Kubota Y, Sasaki S, Kohri K (2009) Mechanical function and gene expression of alpha(1)-adrenoceptor subtypes in dog intravesical ureter. UROLOGY 74:458\u2013462","journal-title":"UROLOGY"},{"key":"5368_CR17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/bph.12123","volume":"169","author":"L Villa","year":"2013","unstructured":"Villa L, Buono R, Fossati N, Rigatti P, Montorsi F, Benigni F, Hedlund P (2013) Effects by silodosin on the partially obstructed rat ureter in vivo and on human and rat isolated ureters. Br J Pharmacol 169:230\u2013238","journal-title":"Br J Pharmacol"},{"key":"5368_CR18","doi-asserted-by":"crossref","first-page":"762e13","DOI":"10.1016\/j.urology.2010.09.034","volume":"77","author":"S Sasaki","year":"2011","unstructured":"Sasaki S, Tomiyama Y, Kobayashi S, Kojima Y, Kubota Y, Kohri K (2011) Characterization of alpha1-adrenoceptor subtypes mediating contraction in human isolated ureters. UROLOGY 77:762e13\u2013762e17","journal-title":"UROLOGY"},{"key":"5368_CR19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4111\/icu.20220254","volume":"64","author":"SH Hong","year":"2023","unstructured":"Hong SH, Jang EB, Hwang HJ, Park SY, Moon HS, Yoon YE (2023) Effect of alpha1D- adrenoceptor blocker for the reduction of ureteral contractions. Invest Clin Urol 64:82\u201390","journal-title":"Invest Clin Urol"},{"key":"5368_CR20","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.3390\/ijms21155339","volume":"21","author":"R Florent","year":"2020","unstructured":"Florent R, Poulain L, N\u2019Diaye M (2020) Drug repositioning of the alpha1-adrenergic receptor antagonist naftopidil: a potential new anti-cancer drug? Int J Mol Sci 21:5339","journal-title":"Int J Mol Sci"},{"key":"5368_CR21","doi-asserted-by":"crossref","first-page":"e00602","DOI":"10.1002\/prp2.602","volume":"8","author":"RGW Proudman","year":"2020","unstructured":"Proudman RGW, Pupo AS, Baker JG (2020) The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants, and antipsychotics for the human \u03b11A, \u03b11B, and \u03b11D-adrenoceptors. Pharmacol Res Perspect 8:e00602","journal-title":"Pharmacol Res Perspect"},{"key":"5368_CR22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-5347(05)66049-1","volume":"166","author":"H Danuser","year":"2001","unstructured":"Danuser H, Weiss R, Abel D, Walter B, Scholtysik G, Mettler D, Studer UE (2001) Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors, alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions. J Urol 166:714\u2013720","journal-title":"J Urol"},{"key":"5368_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00240-007-0100-x","volume":"35","author":"K Davenport","year":"2007","unstructured":"Davenport K, Timoney AG, Keeley FX Jr (2007) Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res 35:207\u2013213","journal-title":"Urol Res"},{"key":"5368_CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.juro.2009.08.106","volume":"183","author":"S Kobayashi","year":"2010","unstructured":"Kobayashi S, Tomiyama Y, Hoyano Y, Yamazaki Y, Sasaki S, Kohri K (2010) Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage. J Urol 183:357\u2013361","journal-title":"J Urol"},{"key":"5368_CR25","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00345-015-1663-8","volume":"34","author":"H Roshani","year":"2016","unstructured":"Roshani H, Weltings S, Dabhoiwala NF, Lamers WH (2016) Pharmacological modulation of ureteric peristalsis in a chronically instrumented conscious pig model: effect of adrenergic and nitrergic modulation. World J Urol (WJU) 34:747\u2013754","journal-title":"World J Urol (WJU)"},{"key":"5368_CR26","doi-asserted-by":"publisher","first-page":"CD008509","DOI":"10.1002\/14651858.CD008509.pub3)","volume":"4","author":"T Campschroer","year":"2018","unstructured":"Campschroer T, Zhu X, Vernooij RW, Lock MT (2018) Alpha-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev 4:CD008509. https:\/\/doi.org\/10.1002\/14651858.CD008509.pub3)","journal-title":"Cochrane Database Syst Rev"},{"key":"5368_CR27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00240-019-01159-5","volume":"48","author":"H Liu","year":"2020","unstructured":"Liu H, Wang S, Zhu W, Lu J, Wang X, Yang W (2020) Comparative efficacy of 22 drug interventions as medical expulsive therapy for ureteral stones: a systematic review and network meta-analysis. Urolithiasis 48:447\u2013457","journal-title":"Urolithiasis"},{"key":"5368_CR28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1590\/s1677-5538.ibju.2020.0548","volume":"48","author":"G Sharma","year":"2022","unstructured":"Sharma G, Pareek T, Kaundal P, Tyagi S, Singh S, Yashaswi T, Devan SK, Sharma AP (2022) Comparison of efficacy of three commonly used alpha-blockers as medical expulsive therapy for distal ureter stones: a systematic review and network meta-analysis. Int Braz J Urol 48:742\u2013759","journal-title":"Int Braz J Urol"},{"key":"5368_CR29","doi-asserted-by":"crossref","first-page":"e27272","DOI":"10.1097\/MD.0000000000027272","volume":"100","author":"ZW Yu","year":"2021","unstructured":"Yu ZW, Wang RH, Zhang CC, Gao JG (2021) The efficacy and safety of alpha-adrenergic blockers for medical expulsion therapy in patients with ureteral calculi: a meta-analysis of placebo-controlled trials. Med (Baltim) 100:e27272","journal-title":"Med (Baltim)"},{"key":"5368_CR30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.euf.2017.05.002","volume":"3","author":"A Skolarikos","year":"2017","unstructured":"Skolarikos A, Ghani KR, Seitz C, van Asseldonk B, Bultitude MF (2017) Medical expulsive therapy in urolithiasis: a review of the quality of the current evidence. Eur Urol Focus 3:27\u201345","journal-title":"Eur Urol Focus"},{"key":"5368_CR31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-642-16499-6_15","volume":"202","author":"MC Michel","year":"2011","unstructured":"Michel MC (2011) \u03b2-Adrenergic receptor subtypes in the urinary tract. Handb Exp Pharmacol 202:307\u2013318","journal-title":"Handb Exp Pharmacol"},{"key":"5368_CR32","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/iju.12093","volume":"20","author":"R Matsumoto","year":"2013","unstructured":"Matsumoto R, Otsuka A, Suzuki T, Shinbo H, Mizuno T, Kurita Y, Mugiya S, Ozono S (2013) Expression and functional role of beta3 -adrenoceptors in the human ureter. Int J Urol 20:1007\u20131014","journal-title":"Int J Urol"},{"key":"5368_CR33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00210-022-02244-0","volume":"395","author":"I Lim","year":"2022","unstructured":"Lim I, Chess-Williams R (2022) Mirabegron attenuates porcine ureteral contractility via alpha1-adrenoceptor antagonism. Naunyn Schmiedebergs Arch Pharmacol 395:839\u2013847","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5368_CR34","doi-asserted-by":"publisher","unstructured":"Atykov M, Ozcelebi E, Sara MY, Gudeloglu A, Iskit AB, Aki FT (2024) In vitro effects of \u03b23- adrenoceptor agonist mirabegron on the human ureter. Neurourol Urodyn (2024, April 25th) https:\/\/doi.org\/10.1002\/nau.25483. [epub ahead of print]","DOI":"10.1002\/nau.25483"},{"key":"5368_CR35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.1476-5381.1992.tb13387.x","volume":"107","author":"M Hern\u00e1ndez","year":"1992","unstructured":"Hern\u00e1ndez M, Prieto D, Simonsen U, Rivera L, Barahona MV, Garc\u00eda-Sacrist\u00e1n A (1992) Noradrenaline modulates smooth muscle activity of the isolated intravesical ureter of the pig through different types of adrenoceptors. Br J Pharmacol 107:924\u2013931","journal-title":"Br J Pharmacol"},{"key":"5368_CR36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(98)00360-4","volume":"352","author":"Y Tomiyama","year":"1998","unstructured":"Tomiyama Y, Hayakawa K, Shinagawa K, Akahane M, Ajisawa Y, Park YC, Kurita T (1998) Beta-adrenoceptor subtypes in the ureteral smooth muscle of rats, rabbits and dogs. Eur J Pharmacol 352:269\u2013278","journal-title":"Eur J Pharmacol"},{"key":"5368_CR37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.92.411","volume":"92","author":"Y Tomiyama","year":"2003","unstructured":"Tomiyama Y, Murakami M, Hayakawa K, Akiyama K, Yamazaki Y, Kojima M, Shibata N, Akahane M (2003) Pharmacological profile of KUL-7211, a selective beta-adrenoceptor agonist, in isolated ureteral smooth muscle. J Pharmacol Sci 92:411\u2013419","journal-title":"J Pharmacol Sci"},{"key":"5368_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1540\/jsmr.36.13","volume":"6","author":"Y Yamamoto","year":"2000","unstructured":"Yamamoto Y, Koike K (2000) The effects of beta-adrenoceptor agonists on KCl-induced rhythmic contraction in the ureter of guinea pig. J Smooth Muscle Res 6:13\u201319","journal-title":"J Smooth Muscle Res"},{"key":"5368_CR39","first-page":"67","volume":"2292","author":"M Murakami","year":"2000","unstructured":"Murakami M, Tomiyama Y, Hayakawa K, Akahane M, Ajisawa Y, Park YC, Ohnishi N, Sugiyama T, Kurita T (2000) Effects of beta-adrenergic stimulation on the acutely obstructed ureter in dogs. J Pharmacol Exp Ther 2292:67\u201375","journal-title":"J Pharmacol Exp Ther"},{"key":"5368_CR40","doi-asserted-by":"crossref","first-page":"1266e1","DOI":"10.1016\/j.urology.2010.12.045","volume":"77","author":"I Wanajo","year":"2011","unstructured":"Wanajo I, Tomiyama Y, Yamazaki Y, Kojima M (2011) Ureteral selectivity of intravenous \u03b2- adrenoceptor agonists in pig model of acute ureteral obstruction: comparison of KUL-7211, a selective \u03b22\/\u03b23 agonist, with isoproterenol, terbutaline, and CL-316243. UROLOGY 77:1266e1\u20131266e6","journal-title":"UROLOGY"},{"key":"5368_CR41","doi-asserted-by":"crossref","first-page":"e011315","DOI":"10.1136\/bmjopen-2016-011315","volume":"6","author":"AJ Tabner","year":"2016","unstructured":"Tabner AJ, Johnson GD, Fakis A, Surtees J, Lennon RI (2016) \u03b2-adrenoreceptor agonists in the management of pain associated with renal colic: a systematic review. BMJ Open 6:e011315","journal-title":"BMJ Open"},{"key":"5368_CR42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s13063-022-06225-9","volume":"23","author":"G Johnson","year":"2022","unstructured":"Johnson G, Tabner A, Fakis A, Sherman R, Chester V, Bedford E, Jackson R, Ratan H, Mason S (2022) Salbutamol for analgesia in renal colic: study protocol for a prospective, randomized, placebo-controlled phase II trial (SARC). Trials 23:352","journal-title":"Trials"},{"key":"5368_CR43","doi-asserted-by":"crossref","first-page":"1280487","DOI":"10.3389\/fmed.2023.1280487","volume":"10","author":"H Song","year":"2024","unstructured":"Song H, Liang L, Liu H, Liu Y, Hu W, Zhang G, Xiao B, Fu M, Li J (2024) Mirabegron for medical expulsive therapy of ureteral stones: a systematic review and meta-analysis. Front Med (Lausanne) 10:1280487","journal-title":"Front Med (Lausanne)"},{"key":"5368_CR44","first-page":"320","volume":"202","author":"KE Andersson","year":"2011","unstructured":"Andersson KE (2011) Muscarinic acetylcholine receptors in the urinary tract. Handb Exp Pharmacol 202:320\u2013344","journal-title":"Handb Exp Pharmacol"},{"key":"5368_CR45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1476-5381.1957.tb01361.x","volume":"12","author":"PJ Fraser","year":"1957","unstructured":"Fraser PJ (1957) Pharmacological actions of pure muscarine chloride. Br J Pharmacol Chemother 12:47\u201352","journal-title":"Br J Pharmacol Chemother"},{"key":"5368_CR46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1620\/tjem.141.489","volume":"14","author":"T Morita","year":"1983","unstructured":"Morita T, Suzuki T, Kondo S, Tsuchida S (1983) Effects of noradrenaline and acetylcholine on ureteral peristalsis. Tohoku J Exp Med 14:489\u2013490","journal-title":"Tohoku J Exp Med"},{"key":"5368_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4196\/kjpp.2011.15.1.37","volume":"15","author":"HW Lee","year":"2011","unstructured":"Lee HW, Baak CH, Lee MY, Kim YC (2011) Spontaneous contractions augmented by cholinergic and adrenergic systems in the human ureter. Korean J Physiol Pharmacol 15:37\u201341","journal-title":"Korean J Physiol Pharmacol"},{"key":"5368_CR48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1476-5381.1972.tb07302.x","volume":"44","author":"RJ Ancill","year":"1972","unstructured":"Ancill RJ, Jackson DM, Redfern PH (1972) The pharmacology of the rat ureter in vivo. Br J Pharmacol 44:628\u2013633","journal-title":"Br J Pharmacol"},{"key":"5368_CR49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1540\/jsmr.42.117","volume":"42","author":"K Smita","year":"2006","unstructured":"Smita K, Sushil Kumar V, Premendran J, Sharma ML (2006) Goat ureter - an alternative model for measuring ureteral peristalsis. J Smooth Muscle Res 42:117\u2013130","journal-title":"J Smooth Muscle Res"},{"key":"5368_CR50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00240-010-0337-7","volume":"39","author":"JL Lv","year":"2011","unstructured":"Lv JL, Tang QN, Hui JH, Lu FD (2011) Efficacy of tolterodine for medical treatment of intramural ureteral stone with vesical irritability. Urol Res (Urolithiasis) 39:213\u2013216","journal-title":"Urol Res (Urolithiasis)"},{"key":"5368_CR51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00240-013-0599-y","volume":"41","author":"JL Lv","year":"2013","unstructured":"Lv JL, Tang QL (2013) Tamsulosin and tolterodine in the medical expulsive therapy for intramural ureteral stones with vesical irritability: a prospective randomized study. Urolithiasis 41:417\u2013421","journal-title":"Urolithiasis"},{"key":"5368_CR52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.16.5.477","volume":"16","author":"LJ Ignarro","year":"1990","unstructured":"Ignarro LJ (1990) Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension 16:477\u2013483","journal-title":"Hypertension"},{"key":"5368_CR53","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0165-1838(95)00042-7","volume":"56","author":"P Alm","year":"1995","unstructured":"Alm P, Zygmunt PK, Iselin C, Larsson B, Uvelius B, Werner S, Andersson KE (1995) Nitric oxide synthase-immunoreactive, adrenergic, cholinergic, and peptidergic nerves of the female rat urinary tract: a comparative study. J Auton Nerv Syst 56:105\u2013114","journal-title":"J Auton Nerv Syst"},{"key":"5368_CR54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00389789","volume":"24","author":"CG Stief","year":"1996","unstructured":"Stief CG, \u00dcckert S, Truss MC, Becker AJ, Machtens S, Jonas U (1996) A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res (Urolithiasis) 24:333\u2013337","journal-title":"Urol Res (Urolithiasis)"},{"key":"5368_CR55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/(SICI)1520-6777(1997)16:3<209::AID-NAU10>3.0.CO;2-G","volume":"16","author":"CE Iselin","year":"1997","unstructured":"Iselin CE, Alm P, Schaad NC, Larsson B, Graber P, Andersson KE (1997) Localization of nitric oxide synthase and heme oxygenase, and functional effects of nitric oxide and carbon monoxide in the pig and human intravesical ureter. Neurourol Urodyn 16:209\u2013227","journal-title":"Neurourol Urodyn"},{"key":"5368_CR56","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000019539","volume":"33","author":"CE Iselin","year":"1998","unstructured":"Iselin CE, Ny L, Larsson B, Schaad NC, Alm P, Graber P, Morel DR, Andersson KE (1998) The nitric oxide synthase\/nitric oxide and heme oxygenase\/carbon monoxide pathways in the human ureter. Eur Urol 33:214\u2013221","journal-title":"Eur Urol"},{"key":"5368_CR57","first-page":"1161","volume":"10","author":"D Saighi","year":"2000","unstructured":"Saighi D, Zerbib M, Thiounn N, Flam T, Conquy S, Jacob L, dal\u2019Ava-Santucci J, Debre B, Dinh Xuan AT (2000) [In vitro study of the modulation of human ureteral tonus by nitric oxide and zaprinast, a phosphodiesterase inhibitor]. Prog Urol 10:1161\u20131168","journal-title":"Prog Urol"},{"key":"5368_CR58","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/01.ju.0000083492.80217.20","volume":"170","author":"D Mastrangelo","year":"2003","unstructured":"Mastrangelo D, Baertschi AJ, Roatti A, Amherdt M, Iselin CE (2003) Nitric oxide production within rat urothelial cells. J Urol 170:1409\u20131414","journal-title":"J Urol"},{"key":"5368_CR59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1464-410x.2000.00613.x","volume":"85","author":"Z Kekec","year":"2000","unstructured":"Kekec Z, Yilmaz U, Sozuer E (2000) The effectiveness of tenoxicam versus isosorbide dinitrate plus tenoxicam in the treatment of acute renal colic. BJU Int 85:783\u2013785","journal-title":"BJU Int"},{"key":"5368_CR60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0090-4295(01)01323-1","volume":"58","author":"Z Hussain","year":"2001","unstructured":"Hussain Z, Inman RD, Elves AW, Shipstone DP, Ghiblawi S, Coppinger SW (2001) Use of glyceryl trinitrate patches in patients with ureteral stones: a randomized, double-blind, placebo-controlled study. UROLOGY 58:521\u2013525","journal-title":"UROLOGY"},{"key":"5368_CR61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/372231a0","volume":"372","author":"AP Somlyo","year":"1994","unstructured":"Somlyo AP, Somlyo AV (1994) Signal transduction and regulation in smooth muscle. Nature 372:231\u2013236","journal-title":"Nature"},{"key":"5368_CR62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1096\/fasebj.7.2.7680013","volume":"7","author":"TM Lincoln","year":"1993","unstructured":"Lincoln TM, Cornwell TL (1993) Intracellular cyclic GMP receptor proteins. FASEB J 7:328\u2013338","journal-title":"FASEB J"},{"key":"5368_CR63","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","volume":"165","author":"T Keravis","year":"2012","unstructured":"Keravis T, Lugnier C (2012) Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. Br J Pharmacol 165:1288\u20131305","journal-title":"Br J Pharmacol"},{"key":"5368_CR64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI111742","volume":"75","author":"BE Jaski","year":"1985","unstructured":"Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS (1985) Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J Clin Invest 75:643\u2013649","journal-title":"J Clin Invest"},{"key":"5368_CR65","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.3390\/ijms21207462","volume":"21","author":"MS Sadek","year":"2020","unstructured":"Sadek MS, Cachorro E, el-Armouche A, K\u00e4mmerer S (2020) Therapeutic implications for PDE2 and cGMP\/cAMP-mediated crosstalk in cardiovascular diseases. Int J Mol Sci 21:7462","journal-title":"Int J Mol Sci"},{"key":"5368_CR66","first-page":"129","volume":"11","author":"FJ Soto","year":"2005","unstructured":"Soto FJ, Hanania NA (2005) Selective phosphodiesterase 4 inhibitors in chronic obstructive lung disease. Curr Opin Pulm Med 11:129\u2013134","journal-title":"Curr Opin Pulm Med"},{"key":"5368_CR67","doi-asserted-by":"crossref","first-page":"E2987","DOI":"10.3390\/jcm9092987","volume":"9","author":"GT Kedia","year":"2020","unstructured":"Kedia GT, \u00dcckert S, Tsikas D, Becker AJ, Kuczyk MA, Bannowsky A (2020) The use of vasoactive drugs in the treatment of male erectile dysfunction: current concepts. J Clin Med (JCM) 9:E2987","journal-title":"J Clin Med (JCM)"},{"key":"5368_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-024-01199-4","author":"V Ganesan","year":"2024","unstructured":"Ganesan V, Agarwal D (2024) Medical advancements in benign prostatic hyperplasia treatments. Curr Urol Rep. https:\/\/doi.org\/10.1007\/s11934-024-01199-4","journal-title":"Curr Urol Rep"},{"key":"5368_CR69","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s003450100221","volume":"19","author":"MC Truss","year":"2001","unstructured":"Truss MC, Stief CG, \u00dcckert S, Becker AJ, Wefer J, Schultheiss D, Jonas U (2001) Phosphodiesterase 1 (PDE1) inhibition in the treatment of lower urinary tract dysfunction: frombench to bedside. World J Urol (WJU) 19:344\u2013350","journal-title":"World J Urol (WJU)"},{"key":"5368_CR70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0090-4295(98)00633-5","volume":"53","author":"SA Kaplan","year":"1999","unstructured":"Kaplan SA, Rodolfo RB, Kohn IJ, Ikeguchi IF, Laor E, Te AE, Martins AC (1999) Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. UROLOGY 53:481\u2013486","journal-title":"UROLOGY"},{"key":"5368_CR71","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/713846815","volume":"27","author":"JR Berman","year":"2001","unstructured":"Berman JR, Berman LA, Lin H, Flaherty E, Lahey N, Goldstein I, Cantey-Kiser J (2001) Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 27:411\u2013420","journal-title":"J Sex Marital Ther"},{"key":"5368_CR72","first-page":"286","volume":"12","author":"A Taher","year":"1994","unstructured":"Taher A, Schulz-Knappe P, Meyer M, Truss MC, Forssmann WG, Stief CG, Jonas U (1994) Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol (WJU) 12:286\u2013291","journal-title":"World J Urol (WJU)"},{"key":"5368_CR73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002400050147","volume":"28","author":"R K\u00fchn","year":"2000","unstructured":"K\u00fchn R, \u00dcckert S, Stief CG, Truss MC, Lietz B, Bischoff E, Schramm M, Jonas U (2000) Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res (Urolithiasis) 28:110\u2013115","journal-title":"Urol Res (Urolithiasis)"},{"key":"5368_CR74","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(01)62833-7","volume":"160","author":"AJ Becker","year":"1998","unstructured":"Becker AJ, Stief CG, Meyer M, Truss MC, Forssmann WG, Jonas U (1998) The effect of the specific phosphodiesterase IV inhibitor rolipram on the ureteral peristalsis of the rabbit in vitro and in vivo. J Urol 160:920\u2013925","journal-title":"J Urol"},{"key":"5368_CR75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1464-410X.2003.04262.x","volume":"92","author":"I Romics","year":"2003","unstructured":"Romics I, Moln\u00e1r DL, Timberg G, Mrklic B, Jelakovic B, K\u00f6szegi G, Blask\u00f3 G (2003) The effect of drotaverine hydrochloride in acute colic pain caused by renal and ureteric stones. BJU Int 92:92\u201396","journal-title":"BJU Int"},{"key":"5368_CR76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00240-006-0073-1","volume":"35","author":"C Gratzke","year":"2007","unstructured":"Gratzke C, \u00dcckert S, Kedia G, Reich O, Schlenker B, Seitz M, Becker AJ, Stief CG (2007) In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteralsmooth muscle: a basic research approach. Urol Res (Urolithiasis) 35:49\u201354","journal-title":"Urol Res (Urolithiasis)"},{"key":"5368_CR77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4111\/icu.2017.58.2.82","volume":"58","author":"CE Montes Cardona","year":"2017","unstructured":"Montes Cardona CE, Garc\u00eda-Perdomo HA (2017) Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: a systematic review and meta-analysis. Invest Clin Urol 58:82\u201389","journal-title":"Invest Clin Urol"},{"key":"5368_CR78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/end.2016.0837","volume":"31","author":"Y Bai","year":"2017","unstructured":"Bai Y, Yang Y, Wang X, Tang Y, Han P, Wang J (2017) Tadalafil facilitates the distal ureteral stone expulsion: a meta-analysis. J Endourol 31:557\u2013563","journal-title":"J Endourol"},{"key":"5368_CR79","first-page":"e14214","volume":"75","author":"G Sharma","year":"2021","unstructured":"Sharma G, Kaundal P, Pareek T, Tyagi S, Sharma AP, Devana SK, Singh SK (2021) Comparison of efficacy of various drugs used for medical expulsive therapy for distal ureter stones: a systematic review and network meta-analysis. Int J Clin Pract 75:e14214","journal-title":"Int J Clin Pract"},{"key":"5368_CR80","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2019.12.012","volume":"219","author":"R Shahbazi","year":"2020","unstructured":"Shahbazi R, Baradaran B, Khordadmehr M, Safaei S, Baghbanzadeh A, Jigari F, Ezzati H (2020) Targeting ROCK signaling in health, malignant and non-malignant diseases. Immunol Lett 219:15\u201326","journal-title":"Immunol Lett"},{"key":"5368_CR81","doi-asserted-by":"crossref","first-page":"104995","DOI":"10.1016\/j.phrs.2020.104995","volume":"159","author":"L Wang","year":"2020","unstructured":"Wang L, Chitano P, Seow CY (2020) Mechano-pharmacology of rho-kinase antagonism in airway smooth muscle and potential new therapy for asthma. Pharmacol Res 159:104995","journal-title":"Pharmacol Res"},{"key":"5368_CR82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2022.08.012","volume":"358","author":"T Sawma","year":"2022","unstructured":"Sawma T, Shaito A, Najm N, Sidani M, Orekhov A, el-Yazbi AF, Iratni R, Eid AH (2022) Role of RhoA and rho-associated kinase in phenotypic switching of vascular smooth muscle cells: implications for vascular function. Atherosclerosis 358:12\u201328","journal-title":"Atherosclerosis"},{"key":"5368_CR83","doi-asserted-by":"crossref","first-page":"C787","DOI":"10.1152\/ajpcell.00441.2022","volume":"324","author":"C Phelps","year":"2023","unstructured":"Phelps C, Chess-Williams R, Moro C (2023) The role of intracellular calcium and rho kinase pathways in G protein-coupled receptor-mediated contractions of urinary bladder urothelium and lamina propria. Am J Physiol Cell Physiol 324:C787\u2013C797","journal-title":"Am J Physiol Cell Physiol"},{"key":"5368_CR84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/nau.20096","volume":"24","author":"SK Hong","year":"2005","unstructured":"Hong SK, Kwak C, Chang Jeong B, Kim BS, Kim HH (2005) Involvement of rho-kinase in the contractile mechanism of human ureteral smooth muscle. Neurourol Urodyn 24:136\u2013141","journal-title":"Neurourol Urodyn"},{"key":"5368_CR85","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1464-410X.2007.07152.x","volume":"100","author":"B Turna","year":"2007","unstructured":"Turna B, Cinar MG, Canda AE, Orhan EC, Tiftik NR, Nazli O, Buyukafsar K (2007) Role of rho-kinase in contractions of ureters from rabbits with unilateral ureteric obstruction. BJU Int 100:1166\u20131171","journal-title":"BJU Int"},{"key":"5368_CR86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ceca.2011.07.003","volume":"50","author":"L Borysova","year":"2011","unstructured":"Borysova L, Shabir S, Walsh MP, Burdyga T (2011) The importance of rho-associated kinase-induced Ca2+ sensitization as a component of electromechanical and pharmaco-mechanical coupling in rat ureteric smooth muscle. Cell Calcium 50:393\u2013405","journal-title":"Cell Calcium"},{"key":"5368_CR87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mad.2018.03.004","volume":"171","author":"I Lim","year":"2018","unstructured":"Lim I, Chess-Williams R, Sellers D (2018) Altered ureteral contractility with ageing: role of the rho kinase pathway. Mech Ageing Dev 171:31\u201336","journal-title":"Mech Ageing Dev"},{"key":"5368_CR88","first-page":"28","volume":"4","author":"CX Lee","year":"2020","unstructured":"Lee CX, Cheah JH, Soule CK, Ding H, Whittaker CA, Karhohs K, Burds AA, Subramanyam KS, Carpenter AE, Eisner BH, Cima MJ (2020) Identification and local delivery of vasodilators for the reduction of ureteral contractions. Nat Biomed Eng 4:28\u201339","journal-title":"Nat Biomed Eng"},{"key":"5368_CR89","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00345-023-04528-3","volume":"41","author":"L Villa","year":"2023","unstructured":"Villa L, Weinhold P, Zaffuto E, Castiglione F, Pozzi E, Ventimiglia E, Buono R, Briganti A, Montorsi F, Salonia A, Hedlund P (2023) The rho-kinase inhibitor Y27632 promotes ureteral relaxation in an in vivo rat model for partial ureteral obstruction. World J Urol (WJU) 41:2541\u20132547","journal-title":"World J Urol (WJU)"},{"key":"5368_CR90","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/BF00169141","volume":"349","author":"CA Maggi","year":"1994","unstructured":"Maggi CA, Giuliani S, Santicioli P (1994) Effect of Bay K8644 and ryanodine on the refractory period, action potential and mechanical response of the guinea pig ureter to electrical stimulation. Naunyn Schmiedeberg\u2019s Arch Pharmacol 349:510\u2013522","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"5368_CR91","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/end.2006.20.565","volume":"20","author":"SA Troxel","year":"2006","unstructured":"Troxel SA, Jones AW, Magliola L, Benson JS (2006) Physiologic effect of nifedipine and tamsulosin on contractility of distal ureter. J Endourol 20:565\u2013568","journal-title":"J Endourol"},{"key":"5368_CR92","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.juro.2008.02.045","volume":"180","author":"RV Floyd","year":"2008","unstructured":"Floyd RV, Borisova L, Bakran A, Hart CA, Wray S, Burdyga TV (2008) Morphology, calcium signaling and mechanical activity in human ureter. J Urol 180:398\u2013405","journal-title":"J Urol"},{"key":"5368_CR93","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/end.2006.20.943","volume":"20","author":"CD Ames","year":"2006","unstructured":"Ames CD, Weld KJ, Dryer ST, Hruby G, Minor SD, Yan Y, Figenshau RS, Bhayani S, Landman J, Venkatesh R (2006) Pharmacologic manipulation of the porcine ureter: acute impact of topical drugs on ureteral diameter and peristaltic activity. J Endourol 20:943\u2013948","journal-title":"J Endourol"},{"key":"5368_CR94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1139\/y05-016","volume":"83","author":"KS Thorneloe","year":"2005","unstructured":"94, Thorneloe KS, Nelson MT (2005) Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can J Physiol Pharmacol 83:215\u2013242","journal-title":"Can J Physiol Pharmacol"},{"key":"5368_CR95","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1994.74.3.595","volume":"74","author":"T Pozzan","year":"1994","unstructured":"Pozzan T, Rizzuto R, Volpe P, Meldolesi J (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 74:595\u2013636","journal-title":"Physiol Rev"},{"key":"5368_CR96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/164_2021_502","volume":"267","author":"A Mathie","year":"2021","unstructured":"Mathie A, Veale EL, Golluscio A, Holden RG, Walsh Y (2021) Pharmacological approaches to studying potassium channels. Handb Exp Pharmacol 267:83\u2013111","journal-title":"Handb Exp Pharmacol"},{"key":"5368_CR97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yjmcc.2005.04.006","volume":"39","author":"A Jahangir","year":"2005","unstructured":"Jahangir A, Terzic A (2005) K+\u2009ATP channel therapeutics at the bedside. J Mol Cell Cardiol 39:99\u2013112","journal-title":"J Mol Cell Cardiol"},{"key":"5368_CR98","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/biom12101341","volume":"12","author":"G Redel-Traub","year":"2022","unstructured":"Redel-Traub G, Sampson KJ, Kass RS, Bohnen MS (2022) Potassium channels as therapeutic targets in pulmonary arterial hypertension. Biomolecules 12:1341","journal-title":"Biomolecules"},{"key":"5368_CR99","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-5347(17)38087-4","volume":"146","author":"H Hedlund","year":"1991","unstructured":"Hedlund H, Mattiasson A, Andersson KE (1991) Effects of pinacidil on detrusor instability in men with bladder outlet obstruction. J Urol 146:1345\u20131347","journal-title":"J Urol"},{"key":"5368_CR100","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.urology.2006.03.039","volume":"68","author":"B Darblade","year":"2006","unstructured":"Darblade B, Behr-Roussel D, Oger S, Hieble JP, Lebret T, Gorny D, Benoit G, Alexandre L, Giuliano F (2006) Effects of potassium channel modulators on human detrusor smooth musclemyogenic phasic contractile activity: potential therapeutic targets for overactive bladder. UROLOGY 68:442\u2013448","journal-title":"UROLOGY"},{"key":"5368_CR101","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1464-410x.1999.00029.x","volume":"83","author":"DG Moon","year":"1999","unstructured":"Moon DG, Byun HS, Kim JJ (1999) A K+\u2009ATP channel opener as a potential treatment modality for erectile dysfunction. BJU Int 83:837\u2013841","journal-title":"BJU Int"},{"issue":"Suppl 2","key":"5368_CR102","first-page":"11","volume":"15","author":"S \u00dcckert","year":"2008","unstructured":"\u00dcckert S, Krahtz C, Becker AJ, Kuczyk MA, Stief CG (2008) In vitro Effekte Von Kalium (K+) Kanal\u00f6ffnern auf die isolierte glatte Muskulatur Des Humanen Ureters. J Urol Urogyn\u00e4kol 15(Suppl 2):11\u201312 (Abstract, presented at the 34th Gemeinsame Tagung der Bayerischen Urologenvereinigung und der \u00d6sterreichischen Gesellschaft f\u00fcr Urologie & Andrologie, Bamberg, Germany, 29-May to 31-May-2008)","journal-title":"J Urol Urogyn\u00e4kol"},{"key":"5368_CR103","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-5347(01)66016-6","volume":"156","author":"RS de Moura","year":"1996","unstructured":"de Moura RS, de Lemos-Neto M (1996) Effects of potassium channel modulators cromakalim, tetraethylammonium (TEA) and glibenclamide on the contractility of the isolated human ureter. J Urol 156:276\u2013280","journal-title":"J Urol"},{"issue":"Suppl 1","key":"5368_CR104","first-page":"389","volume":"107","author":"C Krahtz","year":"2010","unstructured":"Krahtz C, Becker AJ, Mayer ME, Kuczyk MA, Stief CG (2010) Effects of potassium channel openers on parameters of ureteral function - an in vivo animal study. Basic Clin Pharmacol Toxicol (BCPT) 107(Suppl 1):389 [Abstract, presented at the 16th World Congress on Basic and Clinical Pharmacology (World Pharma 2010), Copenhagen, Denmark, 17-July to 23-July-2010]","journal-title":"Basic Clin Pharmacol Toxicol (BCPT)"},{"key":"5368_CR105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000139220","volume":"49","author":"NR Norman","year":"1994","unstructured":"Norman NR, Toombs CF, Khan SA, Buchanan LV, Cimini MG, Gibson JK, Meisheri KD, Shebuski RJ (1994) Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue. Pharmacology 49:86\u201395","journal-title":"Pharmacology"},{"key":"5368_CR106","first-page":"93","volume":"4","author":"MO Fatope","year":"2001","unstructured":"Fatope MO (2001) Retigabine (ASTA Medica). IDrugs 4:93\u201398","journal-title":"IDrugs"},{"key":"5368_CR107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bcpt.13613","volume":"130","author":"I Lim","year":"2021","unstructured":"Lim I, Sellers DJ, Chess-Williams R (2021) Current and emerging pharmacological targets for medical expulsive therapy. Basic Clin Pharmacol Toxicol (BCPT) 130:16\u201322","journal-title":"Basic Clin Pharmacol Toxicol (BCPT)"},{"key":"5368_CR108","doi-asserted-by":"crossref","first-page":"e1175","DOI":"10.1002\/prp2.1175","volume":"12","author":"I Lim","year":"2024","unstructured":"Lim I, Masutani T, Hashitani H, Chess-Williams R, Sellers D (2024) Inhibition of PDE4 isoenzyme attenuates frequency and overall contractility of agonist-evoked ureteral phasic contractions. Pharmacol Res Perspect 12:e1175","journal-title":"Pharmacol Res Perspect"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-05368-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-05368-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:28:00Z","timestamp":1735853280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-05368-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5368"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-05368-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"654"}}